These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11564532)

  • 61. Neurofibrillary tangles in elderly patients with late onset schizophrenia.
    Bozikas VP; Kövari E; Bouras C; Karavatos A
    Neurosci Lett; 2002 May; 324(2):109-12. PubMed ID: 11988339
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study.
    Lippa CF; Smith TW; Swearer JM
    Ann Neurol; 1994 Jan; 35(1):81-8. PubMed ID: 8285597
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
    Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
    Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3.
    Tata DA; Marciano VA; Anderson BJ
    J Comp Neurol; 2006 Sep; 498(3):363-74. PubMed ID: 16871536
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y; Ishizu H; Ishiguro K; Itoh N; Terada S; Haraguchi T; Kawai K; Kuroda S
    Neuroreport; 2000 Aug; 11(11):2473-7. PubMed ID: 10943706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased expression of p130 in Alzheimer disease.
    Previll LA; Crosby ME; Castellani RJ; Bowser R; Perry G; Smith MA; Zhu X
    Neurochem Res; 2007; 32(4-5):639-44. PubMed ID: 17006760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease.
    Moore D; Iritani S; Chambers J; Emson P
    Neuroreport; 2000 Nov; 11(17):3799-803. PubMed ID: 11117494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.
    Thorns V; Hansen L; Masliah E
    Exp Neurol; 1998 Mar; 150(1):14-20. PubMed ID: 9514829
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density.
    Falke E; Nissanov J; Mitchell TW; Bennett DA; Trojanowski JQ; Arnold SE
    Am J Pathol; 2003 Oct; 163(4):1615-21. PubMed ID: 14507668
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia.
    Casanova MF; Rothberg B
    Schizophr Res; 2002 May; 55(1-2):19-24. PubMed ID: 11955960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MRI observation of hippocampal degeneration in Alzheimer's disease: a forgotten case.
    D'Angelo E; Mazzarello P
    Funct Neurol; 2013; 28(3):245-6. PubMed ID: 24139660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.
    Chung JK; Nakajima S; Plitman E; Iwata Y; Uy D; Gerretsen P; Caravaggio F; Chakravarty MM; Graff-Guerrero A
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):923-39. PubMed ID: 27526990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. C-terminal fragments of amyloid-beta peptide cause cholinergic axonal degeneration by a toxic effect rather than by physical injury in the nondemented human brain.
    Kasa P; Papp H; Zombori J; Mayer P; Checler F
    Neurochem Res; 2003 Apr; 28(3-4):493-8. PubMed ID: 12675137
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.
    Lee SC; Zhao ML; Hirano A; Dickson DW
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia.
    Casanova MF; Carosella NW; Gold JM; Kleinman JE; Weinberger DR; Powers RE
    Psychiatry Res; 1993 Oct; 49(1):41-62. PubMed ID: 8140181
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Senile plaques exert no mass lesion effect on surrounding neurons.
    Casanova MF; Hill WD; Pourdihimi B
    J Neurosci Methods; 2001 Sep; 110(1-2):125-33. PubMed ID: 11564532
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.